Leptin in immunology

Journal of Immunology

Volumn 174, Issue 6, 2005, Pages 3137-3142

  Matarese, Giuseppe ^a   Moschos, Stergios ^b   Mantzoros, Christos S ^c,d  

^a CNR   (Italy)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LEPTIN;

CYTOKINE PRODUCTION; HOMEOSTASIS; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; NEUROENDOCRINE SYSTEM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; TH1 CELL;

EID: 14844363594     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.6.3137     Document Type: Short Survey

References (83)

1. Sanz, J. J., J. Moreno, S. Merino, and T. Gustavo. 2004. A trade-off between two resource-demanding functions: post-nuptial moult and immunity during reproduction in male pied flycatchers. J. Anim. Ecol. 73:441.
2. Buttgereit, F., G. R. Burmester, and M. D. Brand. 2000. Bioenergetics of immune functions: fundamental and therapeutic aspects. Immunol. Today 21:192.
3. Moret, Y., and P. Schmid-Hempel. 2000. Survival for immunity: the price of immune system activation for bumblebee workers. Science 290:1166.
4. Samartin, S., and R. Chandra. 2001. Obesity, overnutrition and the immune system. Nutr. Res. 21:243.
5. Chan, J. L., K. Heist, A. M. DePaoli, J. D. Veldhuis, and C. S. Mantzoros. 2003. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J. Clin. Invest. 111:1409.
6. Ahima, R. S., D. Prabakaran, C. Mantzoros, D. Qu, B. Lowell, E. Maratos-Flier, and J. S. Flier. 1996. Role of leptin in the neuroendocrine response to fasting. Nature 382:250.
7. Bennett, B. D., G. P. Solar, J. Q. Yuan, J. Mathias, G. R. Thomas, and W. Matthews. 1996. A role for leptin and its cognate receptor in hematopoiesis. Curr. Biol. 6:1170.
8. Sierra-Honigmann, M. R., A. K. Nath, C. Murakarni, G. Garcia-Cardena, A. Papapetropoulos, W. C. Sessa, L. A. Madge, J. S. Schechner, M. B. Schwabb, P. J. Polverini, and J. R. Flores-Riveros. 1998. Biological action of leptin as an angiogenic factor. Science 281:1683.
9. Pond, C. M. 2000. Adipose tissue, the anatomists' Cinderella, goes to the ball at last, and meets some influential partners. Postgrad. Med. J. 76:671.
10. Laharrague, P., D. Larrouy, A. M. Fontanilles, N. Truel, A. Campfield, R. Tenenbaum, J, Galitzky, J. X. Corberand, L. Penicaud, and L. Casteilla. 1998. High expression of leptin by human bone marrow adipocytes in primary culture. FASEB J. 12:747.
11. Zhang, F., M. B. Basinski, J. M. Beats, S. L. Briggs, L. M. Churgay, D. K. Clawson, R. D. DiMarchi, T. C. Furman, J. E. Hale, H. M. Hsiung, et al. 1997. Crystal structure of the obese protein leptin-E100. Nature 387:206.
12. Tartaglia, L. A. 1997. The leptin receptor. J. Biol. Chem. 272:6093.
13. Lord, G. M., G. Matarese, J. K. Howard, R. J. Baker, S. R. Bloom, and R. I. Lechler. 1998. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394:897.
14. Zhao, Y., R. Sun, L. You, C. Gao, and Z. Tian. 2003. Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochem. Biophys. Res. Commun. 300:247.
15. Zarkesh-Esfahani, H., G. Pockley, R. A. Metcalfe, M. Bidlingmaier, Z. Wu, A. Ajami, A. P. Weetman, C. J. Strasburget, and R. J. Ross. 2001. High-dose leptin activates human leukocytes via receptor expression on monocytes. J. Immunol. 167:4593.
16. Caldefie-Chezet, F., A. Poulin, A. Tridon, B. Sion, and M. P. Vasson. 2001. Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action? J. Leukocyte Biol. 69:414.
17. Baumann, H., K. K. Morella, D. W. White, M. Dembski, P. S. Bailon, H. Kim, C. F. Lai, and L. A. Tartaglia. 1996. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc. Natl. Acad. Sci. USA 93:8374.
18. Bjorbaek, C., K. El Haschimi, J. D. Frantz, and J. S. Flier. 1999. The role of SOCS-3 in leptin signaling and leptin resistance. J. Biol. Chem. 274:30059.
19. Cheng, A., N. Uetani, P. D. Simoncic, V. P. Chaubey, A. Lee-Loy, C. J. McGlade, B. P. Kennedy, and M. L. Tremblay. 2002. Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev. Cell 2:497.
20. Martin-Romero, C., and V. Sanchez-Margalet. 2001. Human leptin activates PI3K and MAPK pathways in human peripheral blood mononuclear cells: possible role of Sam68. Cell. Immunol. 212:83.
21. Sanchez-Margalet, V., and C. Martin-Romero. 2001. Human leptin signaling in human peripheral blood mononuclear cells: activation of the JAK-STAT pathway. Cell. lmmunol. 211:30.
22. Najib, S., and V. Sanchez-Margalet. 2002. Human leptin promotes survival of human circulating blood monocytes prone to apoptosis by activation of p42/44 MAPK pathway. Cell. Immunol. 220:143.
23. Bates, S. H., J. V. Gardiner, R. B. Jones, S. R. Bloom, and C. J. Bailey. 2002. Acute stimulation of glucose uptake by leptin in 16 muscle cells. Horm. Metab. Res. 34:111.
24. Chandra, R. K. 1980. Cell-mediated immunity in genetically obese C57BL/6J (ob/ob) mice. Am. J. Clin. Nutr. 33:13.
25. Mandel, M. A., and A. A. Mahmoud. 1978. Impairment of cell-mediated immunity in mutation diabetic mice (db/db). J. Immunol. 120:1375.
26. Ozata, M., I. C. Ozdemir, and J. Licinio. 1999. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J. Clin. Endocrinol. Metab. 84:3686.
27. Farooqi, I. S., G. Matarese, G. M. Lord, J. M. Keogh, E. Lawrence, C. Agwu, V. Sanna, S. A. Jebb, F. Perna, S. Fontana, et al. 2002. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J. Clin. Invest. 110:1093.
28. + lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin. Rheumatol. 18:394.
29. Zhang, Y., J. T. Wilsey, C. D. Frase, M. M. Matheny, B. S. Bender, S. Zolotukhin, and P. J. Scarpace. 2002, Peripheral but not central leptin prevents the immunosuppression associated with hypoleptinemia in rats. J. Endocrinol. 174:455.
30. Mancuso, P., A. Gottschalk, S. M. Phare, M. Peters-Golden, N. W. Lukacs, and G. B. Huffnagle. 2002. Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J. Immunol. 168:4018.
31. Mancuso, P., C. Canetti, A. Gottschalk, P. K. Tithof, and M. Peters-Golden. 2004. Leptin augments alveolar macrophage leukotriene synthesis by increasing phospholipase activity and enhancing group IVC iPLA2 (cPLA2γ) protein expression. Am. J. Physiol. 287:L497.
32. Loffreda, S., S. Q. Yang, H. Z. Lin, C. L. Karp, M. L. Brengman, D. J. Wang, A. S. Klein, G. B. Bulkley, C. Bao, P. W. Noble, et al. 1998. Leptin regulates proinflammatory immune responses. FASEB J. 12:57.
33. Gainsford, T., T. A. Willson, D. Metcalf, E. Handman, C. McFarlane, A. Ng, N. A. Nicola, W. S. Alexander, and D. J. Hilton. 1996. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc. Natl. Acad. Sci. USA 93:14564.
34. Caldefie-Chezet, F., A. Poulin, and M. P. Vasson. 2003. Leptin regulates functional capacities of polymorphonuclear neutrophils. Free Radical Res. 37:809.
35. Zarkesh-Esfahani, H., A. G. Pockley, Z. Wu, P. G. Hellewell, A. P. Weetman, and R. J. Ross. 2004. Leptin indirectly activates human neutrophils via induction of TNF-α. J. Immunol. 172:1809.
36. Tian, Z., R. Sun, H. Wei, and B. Gao. 2002. Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation. Biochem. Biophys. Res. Commun. 298:297.
37. Howard, J. K., G. M. Lord, G. Matarese, S. Vendetti, M. A. Ghatei, M. A. Ritter, R. I. Lechler, and S. R. Bloom. 1999. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J. Clin. Invest. 104:1051.
38. Martin-Romero, C., J. Santos-Alvarez, R. Goberna, and V. Sanchez-Margalet. 2000. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell. Immunol. 199:15.
39. Lord, G. M., G. Matarese, J. K. Howard, S. R. Bloom, and R. I. Lechler. 2002. Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J. Leukocyte Biol. 72:330.
40. Fujita, Y., M. Murakami, Y. Ogawa, H. Masuzaki, M. Tanaka, S. Ozaki, K. Nakao, and T. Mimori. 2002. Leptin inhibits stress-induced apoptosis of T lymphocytes. Clin. Exp. Immunol. 128:21.
41. Akaishi, H., K. Takeda, T. Kaisho, R. Shineha, S. Satomi, J. Takeda, and S. Akira. 1998. Defective IL-2-mediated IL-2 receptor α chain expression in Stat3-deficient T lymphocytes. Int. Immunol. 10:1747.
42. Takeda, K., T. Kaisho, N. Yoshida, J. Takeda, T. Kishimoto, and S. Akira. 1998. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 161:4652.
43. Lamas, O., J. A. Martinez, and A. Marti. 2004. Energy restriction restores the impaired immune response in overweight (cafeteria) rats. J. Nutr. Biochem. 15:418.
44. Palacio, A., M. Lopez, F. Perez-Bravo, F. Monkeberg, and L. Schlesinger. 2002. Leptin levels are associated with immune response in malnourished infants. J. Clin. Endocrinol. Metab. 87:3040.
45. + children during highly active antiretroviral therapy. Clin. Endocrinol. 57:643.
46. Chan, J. L., S. J. Moschos, J. Bullen, K. Heist, X. Li, Y. B. Kim, B. B. Kahn, and C. S. Mantzoros. 2005. Leptin activates STAT3 signaling in PBMCs in vivo and regulates soluble TNF-α receptor levels in humans with relative leptin deficiency. J. Clin. Endocrinol. Metab. In press.
47. Lamas, O., J. A. Martinez, and A. Marti. 2002. T-helper lymphopenia and decreased mitogenic response in cafeteria diet-induced obese rats. Nutr. Res. 22:496.
48. Tanaka, S., F. Isoda, Y. Ishihara, M. Kimura, and T. Yamakawa. 2001. T lymphopaenia in relation to body mass index and TNF-α in human obesity: adequate weight reduction can be corrective. Clin. Endocrinol. 54:347.
49. Rabinovitch, A., W. L. Suarez-Pinzon, O. Sorensen, R. V. Rajotte, and R. F. Power. 1997. TNF-α down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice. J. Immunol. 159:6298.
50. Chan, J. L., J. Bullen, V. Stoyneva, A. M. DePaoli, C. Addy, and C. S. Mantzoros. 2005. r-metHuLeptin administration to achieve high physiologic or pharmacologic leptin levels does not alter circulating inflammatory marker levels in humans with leptin sufficiency or excess. J. Clin. Endocrinol. Metab. In press.
51. Faggioni, R., G. Fantum, C. Gabay, A. Moser, C. A. Dinarello, K. R. Feingold, and C. Grunfeld. 1999. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am. J. Physiol. 276:R136.
52. Faggioni, R., A. Moser, K. R. Feingold, and C. Grunfeld. 2000. Reduced leptin levels in starvation increase susceptibility to endotoxic shock. Am. J. Pathol. 156:1781.
53. Takahashi, N., W. Waelput, and Y. Guisez. 1999. Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J. Exp. Med. 189:207.
54. Bernotiene, E., G. Palmer, D. Talabot-Ayer, I. Szalay-Quinodoj, M. L. Aubert, and C. Gabay. 2004. Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice. Arthritis Res. Ther. 6:R256.
55. Williams, L., L. Bradley, A. Smith, and B. Foxwell. 2004. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J. Immunol. 172:507.
56. Siegmund, B., K. C. Lear-Kaul, R. Faggioni, and G. Fantuzzi. 2002. Leptin deficiency, not obesity, protects mice from Con A-induced hepatitis. Eur. J. Immunol. 32:552.
57. Faggioni, R., J. Jones-Carson, D. A. Reed, C. A. Dinarello, K. R. Feingold, C. Grunfeld, and G. Fantuzzi. 2000. Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor α and IL-18. Proc. Natl. Acad. Sci. USA 97:2367.
58. Mykoniatis, A., P. M. Anton, M. Wlk, C. C. Wang, L. Ungsunan, S. Bluher, M. Venihaki, S. Simeonidis, J. Zacks, D. Zhao, et al. 2003. Leptin mediates Clostridium difficile toxin A-induced enteritis in mice. Gastroenterology 124:683.
59. Busso, N., A. So, V. Chobaz-Peclat, C. Motard, E. Martinez-Soria, D. Talabot-Ayer, and C. Gabay. 2002. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J. Immunol. 168:875.
60. Xu, H., G. T. Barnes, Q. Yang, G. Tan, D. Yang, C. J. Chou, J. Sole, A. Nichols, J. S. Ross, L. A. Tartaglia, and H. Chen. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112:1821.
61. Sanna, V., A. Di Giacomo, A. La Cava, R. I. Lechler, S. Foncana, S. Zappacosta, and G. Matarese. 2003. Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J. Clin. Invest. 111:241.
62. Matarese, G., V. Sanna, A. Di Giacomo, G. M. Lord, J. K. Howard, S. R. Bloom, R. I. Lechler, S. Fontana, and S. Zappacosta. 2001. Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males. Eur. J. Immunol. 31:1324.
63. Matarese, G., A. Di Giacomo, V. Sanna, G. M. Lord, J. K. Howard, A. Di Tuoro, S. R. Bloom, R. I. Lechler, S. Zappacosta, and S. Fontana, 2001. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J. Immunol. 166:5909.
64. Tarzi, R. M., H. T. Cook, I. Jackson, C. D. Pusey, and G. M. Lord. 2004. Leptin-deficient mice are protected from accelerated nephrotoxic nephritis. Am. J. Pathol. 164:385.
65. Matarese, G., V. Sanna, R. I. Lechler, N. Sarvetnick, S. Fontana, S. Zappacosta, and A, La Cava. 2002. Leptin accelerates autoimmune diabetes in female NOD mice. Diabetes 51:1356.
66. Siegmund, B., J. A. Sennello, J. Jones-Carson, F. Gamboni-Robertson, H. A. Lehr, A. Batra, I. Fedke, M. Zeitz, and G. Fantuzzi. 2004. Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice. Gut 53:965.
67. Gaetke, L. M., H. S. Oz, W. J. de Villiers, G. W. Varilek, and R. C. Frederich. 2002. The leptin defense against wasting is abolished in the IL-2-deficient mouse model of inflammatory bowel disease. J. Nutr. 132:893.
68. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22:531.
69. O'Shea, J. J., A. Ma, and P. Lipsky. 2002. Cytokines and autoimmunity. Nat. Rev. Immunol. 2:37.
70. Mazziorti, G., A. B. Parkes, M. Lage, L. D. Premawardhana, F. F. Casanueva, and J. H. Lazarus. 2004. High leptin levels in women developing postpartum thyroiditis. Clin. Endocrinol. 60:208.
71. Zhan, M., H. Zhao, R. Yang, and Z. C. Han. 2004. Serum leptin levels in patients with idiopathic thrombocytopenic purpura. Eur. J. Haematol. 72:348.
72. Garcia-Gonzalez, A., L. Gonzalez-Lopez, I. C. Valera-Gonzalez, E. G. Cardona-Munoz, M. Salazar-Paramo, M. Gonzalez-Ortiz, E. Martinez-Abundis, and J. I. Gamez-Nava. 2002. Serum leptin levels in women with systemic lupus erythematosus. Rheumatol. Int. 22:138.
73. Batocchi, A. P., M. Rotondi, M. Caggiula, G. Frisullo, F. Odoardi, V. Nociti, C. Carella, P. A. Tonali, and M. Mirabella, 2003. Leptin as a marker of multiple sclerosis activity in patients treated with interferon-β. J. Neuroimmunol. 139:150.
74. Frisullo, G., F. Angelucci, M. Mirabella, M. Caggiula, K. Patanella, V. Nociti, P. A. Tonali, and A. P. Batocchi, 2004. Leptin enhances the release of cytokines by peripheral blood mononuclear cells from relapsing multiple sclerosis patients. J. Clin. Immunol. 24:287.
75. Evereklioglu, C., H. S. Inaloz, N. Kirtak, S. Doganay, M. Bulbul, E. Ozerol, H. Er, and E. Ozbek. 2002, Serum leptin concentration is increased in patients with Behçet's syndrome and is correlated with disease activity. Br. J. Dermatol. 147:331.
76. Weisberg, S. P., D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante, Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112:1796.
77. Mantzoros, C. S., S. Moschos, I. Avramopoulos, V. Kaklamani, A. Liolios, D, E. Doulgecakis, I. Griveas, N. Katsilambros, and J. S. Flier. 1997. Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans. J. Clin. Endocrinol. Metab. 82:3408.
78. Papathanassoglou, E. D., J. A. Moynihan, M. H. Ackerman, and C. S. Mantzoros. 2001. Serum leptin levels are higher but are not independently associated with severity or mortality in the multiple organ dysfunction/systemic inflammatory response syndrome: a matched case control and a longitudinal study. Clin. Endocrinol. 54:225.
79. Shamsuzzaman, A. S., M. Winnicki, R. Wolk, A. Svatikova, B. G. Phillips, D. E. Davison, P. B. Berger, and V. K. Somers. 2004. Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 109:2181.
80. Mito, N., T. Hosoda, C. Kato, and K. Sato. 2000. Change of cytokine balance in diet-induced obese mice. Metabolism 49:1295.
81. Mito, N., H. Yoshino, T. Hosoda, and K. Sato. 2004. Analysis of the effect of leptin on immune function in vivo using diet-induced obese mice. J. Endocrinol. 180:167.
82. Mantovani, G., A. Maccio, C. Madeddu, and E. Massa. 2003. Cancer-related cachexia and oxidative stress: beyond current therapeutic options. Expert Rev. Anticancer Ther. 3:381.
83. Matarese, G., V. Sanna, S. Fontana, and S. Zappacosta. 2002. Leptin as a novel therapeutic target for immune intervention. Curr. Drug Targets Inflamm. Allergy 1:13.